---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-21-013049"
form_type: "8-K/A"
ticker: "ZOMDF"
cik: "0001684144"
company_name: "Zomedica Corp."
filed_at: "2021-12-10T23:59:59+00:00"
generated_at: "2026-06-28T02:06:07.630831+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# Zomedica files pro forma financials for Pulse Veterinary acquisition; $71.9M cash price

## Summary
- Preliminary purchase price of $71.9M funded from cash; pro forma cash after deal $197.7M.
- Pro forma 2020 net loss $13.4M, including $1.5M amortization on acquired intangibles.
- Acquired intangible assets valued at $33.65M with 11-19 year useful lives; goodwill $44.9M.
- Branford PVT generated $7.1M revenue in 2020 and $8.5M in 9mo 2021; combined entity net loss.
- Audited financial statements of Branford PVT filed as Exhibit 99.1.

## SEC filing metadata
- accession: 0001654954-21-013049
- form_type: 8-K/A
- ticker: ZOMDF
- cik: 0001684144
- company_name: Zomedica Corp.
- filed_at: 2021-12-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1684144/000165495421013049/0001654954-21-013049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1684144/000165495421013049/zom_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-21-013049
- JSON: https://secwatch.observer/filing/0001654954-21-013049.json
- Plain text: https://secwatch.observer/filing/0001654954-21-013049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.